Pharma tariffs would raise U.S. drug costs by 51 billion annually, report finds

Get the Full StoryA 25 U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly 51 billion annually, boosting U.S. prices by as much as 12.9 if passed on, a report commissioned by the industry s U.S. trade group and reviewed by Reuters shows.

Share: